Article | October 25, 2022

The Surprising Path To The Future Of Diagnostic Clinical Trials


In recent years, there has been a significant increase in patient demand for early detection diagnostic modalities within healthcare. At-home tests for allergies, fertility, cholesterol, and more were already becoming popular, but since the advent of the COVID-19 pandemic, sales for diagnostic devices have rapidly increased.1 And with continued advances in regulation and technology, home diagnostics is moving into other sectors, from diabetes and infectious diseases to heart disease.1 In-clinic or point-of-care early detection and diagnostic testing for cancer has also skyrocketed.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader

Elligo Health Research®